News Focus
News Focus
Replies to #62849 on Biotech Values
icon url

DewDiligence

05/22/08 8:46 AM

#62850 RE: genisi #62849

>You don't think that shorter duration might result in better compliance and commercial adoption?<

I think the overall duration of treatment is what matters. VRTX’s “12+12” regimen is still 24 weeks of interferon and 24 weeks of ribavirin.